This topic contains a solution. Click here to go to the answer

Author Question: Which of the following clients are at risk for folic acid deficiency? a. 23-yo woman taking oral ... (Read 56 times)

D2AR0N

  • Hero Member
  • *****
  • Posts: 561
Which of the following clients are at risk for folic acid deficiency?
 
  a. 23-yo woman taking oral contraceptives
  b. 14-yo adolescent who plays basketball and football
  c. 75-yo man with benign prostatic hypertrophy
  d. 55-yo woman experiencing menopause

Question 2

While taking a client's history, the nurse recognizes the client has been taking a drug that with prolonged use may cause anemia due to blood loss. The client probably is taking:
 
  a. tetracycline c. indomethacin
  b. aluminum-containing antacids d. diphenhydramine



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wfdfwc23

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: A

Feedback
A Correct: Oral contraceptives increase the need for folic acid.
B Incorrect: This does not lead to increased need for folic acid.
C Incorrect: This does not lead to increased need for folic acid.
D Incorrect: This does not lead to increased need for folic acid.

Answer to Question 2

ANS: C

Feedback
A Incorrect: This should not lead to blood loss.
B Incorrect: This should not lead to blood loss.
C Correct: Indomethacin can cause GI bleeding, especially with prolonged use.
D Incorrect: This should not lead to blood loss.



D2AR0N

  • Hero Member
  • *****
  • Posts: 561
Both answers were spot on, thank you once again




 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

For a complete list of videos, visit our video library